Fr. 135.00

Sparking Signals - Kinases as Molecular Signaltransducers and Pharmacological Drug Targets in Inflammation

Inglese · Tascabile

Spedizione di solito entro 6 a 7 settimane

Descrizione

Ulteriori informazioni

Protein phosphorylation is an essential post-translational modification that modulates cell-cell communication. Substrate phosphorylation by protein kinases controls intracellular signal transduction pathways that mediate cell proliferation, migration, differentiation, and metabolism. The importance of the protein kinase family is underscored by numerous disease states that arise due to dysregulation of kinase activity. Recent progress in understanding the molecular regulation of kinases has led to the development of new therapeutics based on the inhibition of kinase activity. Inhibitors that target protein kinases have proven efficacious in clinical settings and their continued development is the current focus of many drug discovery groups.

Sommario

Proteomics-Based Strategies in Kinase Drug Discovery.- PKC Isotype Functions in T Lymphocytes.- Migration, Cell-Cell Interaction and Adhesion in the Immune System.- Molecular Mechanisms that Control Leukocyte Extravasation Through Endothelial Cell Contacts.- Fragment-Based Drug Discovery Using Rational Design.- Systems Biology of T Cell Activation.- Solving the IRAK-4 Enigma: Application of Kinase-Dead Knock-In Mice.- Sensing, Presenting, and Regulating PAMPS.- The Role of Diacylglycerol Kinases in T Cell Anergy.

Riassunto

Protein phosphorylation is an essential post-translational modification that modulates cell–cell communication. Substrate phosphorylation by protein kinases controls intracellular signal transduction pathways that mediate cell proliferation, migration, differentiation, and metabolism. The importance of the protein kinase family is underscored by numerous disease states that arise due to dysregulation of kinase activity. Recent progress in understanding the molecular regulation of kinases has led to the development of new therapeutics based on the inhibition of kinase activity. Inhibitors that target protein kinases have proven efficacious in clinical settings and their continued development is the current focus of many drug discovery groups.

Dettagli sul prodotto

Con la collaborazione di Gottfried Baier (Editore), Arne Bonin (Editore), Arne von Bonin (Editore), Burkhar Schraven (Editore), Burkhart Schraven (Editore), Arne von Bonin (Editore), Ulrich Zügel (Editore), Ulrich Zügel et al (Editore)
Editore Springer, Berlin
 
Lingue Inglese
Formato Tascabile
Pubblicazione 06.10.2010
 
EAN 9783642092626
ISBN 978-3-642-09262-6
Pagine 187
Dimensioni 152 mm x 11 mm x 229 mm
Peso 304 g
Illustrazioni XIV, 187 p.
Serie Ernst Schering Foundation Symposium Proceedings
Ernst Schering Foundation Symposium Proceedings
Categorie Scienze naturali, medicina, informatica, tecnica > Medicina > Farmacia

Biochemie, C, Immunologie, Immunology, Life Sciences, biochemistry, Pharmacology, Biomedical and Life Sciences, Biochemistry, general, Pharmacology/Toxicology

Recensioni dei clienti

Per questo articolo non c'è ancora nessuna recensione. Scrivi la prima recensione e aiuta gli altri utenti a scegliere.

Scrivi una recensione

Top o flop? Scrivi la tua recensione.

Per i messaggi a CeDe.ch si prega di utilizzare il modulo di contatto.

I campi contrassegnati da * sono obbligatori.

Inviando questo modulo si accetta la nostra dichiarazione protezione dati.